Lexaria Bioscience (LEXX) Income from Non-Controlling Interests (2019 - 2025)
Historic Income from Non-Controlling Interests for Lexaria Bioscience (LEXX) over the last 7 years, with Q4 2025 value amounting to -$2496.0.
- Lexaria Bioscience's Income from Non-Controlling Interests rose 1478.32% to -$2496.0 in Q4 2025 from the same period last year, while for Nov 2025 it was -$9160.0, marking a year-over-year increase of 1295.26%. This contributed to the annual value of -$9593.0 for FY2025, which is 2792.1% up from last year.
- As of Q4 2025, Lexaria Bioscience's Income from Non-Controlling Interests stood at -$2496.0, which was up 1478.32% from -$1390.0 recorded in Q3 2025.
- In the past 5 years, Lexaria Bioscience's Income from Non-Controlling Interests ranged from a high of -$1390.0 in Q3 2025 and a low of -$45696.0 during Q3 2022
- For the 5-year period, Lexaria Bioscience's Income from Non-Controlling Interests averaged around -$10938.5, with its median value being -$9555.0 (2021).
- Per our database at Business Quant, Lexaria Bioscience's Income from Non-Controlling Interests crashed by 27062.27% in 2022 and then soared by 8163.16% in 2024.
- Lexaria Bioscience's Income from Non-Controlling Interests (Quarter) stood at -$10325.0 in 2021, then fell by 29.41% to -$13362.0 in 2022, then skyrocketed by 57.23% to -$5715.0 in 2023, then surged by 48.75% to -$2929.0 in 2024, then grew by 14.78% to -$2496.0 in 2025.
- Its Income from Non-Controlling Interests stands at -$2496.0 for Q4 2025, versus -$1390.0 for Q3 2025 and -$1514.0 for Q2 2025.